Value proposition

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases.

BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress.

BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years.

Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: www.biontech.com/careers

🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html

🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

Biotechnology, Individualized cancer medicine, Patient-specific immunotherapy, mRNA therapeutics, Cell therapy, Antibody therapeutics, Small molecule immunomodulators, Tailored therapeutics, Immunotherapy, Oncology, CAR T, TCR, Bispecific antibodies, Rare diseases, and Infectious diseases